The Norwegian experience with nationwide implementation of fetal <scp><i>RHD</i></scp> genotyping and targeted routine antenatal <scp>anti‐D</scp> prophylaxis

Abstract

Nationwide targeted RAADP is implemented and included in the Norwegian maternity care programme. Compliance to sample uptake should further improve in some regions. A remaining issue to fulfil is the documentation of the accuracy of the fetal RHD-typing at all sites. Post-natal prophylaxis will then be guided by the fetal RHD result. Dedicated registries will ensure data to evaluate the expected reduction in pregnancy-related RhD immunisations, which is the final success criterion of the programme.